On Achema 2024, we are going to present you Tofflon Latest Technology
Development for the BR-C Stainless Steel Cultivation System.
The BR-C Stainless Steel Cultivation System is a cutting-edge bioreactor engineered to cater to the expanding needs of the biopharmaceutical industry, this innovative bioreactor is designed in sync with current industry trends, and its unique features and capabilities, ensuring exceptional performance.
- Adaptability to Biologics Growth: With the biopharmaceutical market's expansion, the BR-C system's capability for micro-carrier cultivation of Vero cells and other cell lines like CHO, BHK, SF9, and HEK293 aligns perfectly with the need for versatile and salable bioreactor solutions that can accommodate a variety of biologics production.
- Digital Integration: The BR-C system's potential for automation and digital integration resonates with the trend of digitalization in bio-processing. This feature allows for better process control, real-time monitoring, and data management, which are essential for achieving consistent and high-quality outputs.
- Sustainability Emphasis: The system's design considerations for sustainability and the use of materials like SS. 316L stainless steel and insulation options like aluminum silicate and rock wool reflect the commitment to environmentally friendly.
- Vaccine Manufacturing: The BR-C system is particularly well-suited for vaccine production, where the ability to cultivate Vero cells, a common substrate for viral vaccines, is essential. Its design supports the large-scale manufacturing processes required for global vaccine distribution.
- Biopharmaceutical Production: The system's adaptability for various cell lines makes it an ideal choice for the production of a wide range of bio pharmaceutical products, including monoclonal antibodies,recombinant proteins, virus vector, etc.., which are in high demand for treating various diseases.
- R&D and Scale-Up: Research institutions and biotech companies can leverage the BR-C system's flexibility for R&D purposes, as well as for scaling up processes from lab to commercial production.
- Contract Manufacturing: CMOs can utilize the BR-C system's robustness and scalability to cater to the diverse needs of their clients, enhancing their service offerings and remaining competitive in the market.
- Customized gas distribution, gas sparging and exhausting design to satisfy different applications.
- CFD analysis and offering varieties of agitating solutions.
- Definable human-machine interface (HMl) with P&ID diagram and access level control.
- Rich process interface, cascade control strategy and implementation plan, convenient to scale up.
- Software developed by Tofflon is in line with the requirements of GAMP5, 21CFR Part11.
- The function of multiple recipes management is optional.
- Glass bioreactor for R&D application and seed cultivation from 0.5L to 20L.
- Single use bioreactor for CAPEX saving form 50L to 2,000L.
- Stainless steel bioreactor for OPEX saving from 10L to 15,000L, and other volumes could be determined.
In summary, Tofflon BR-C Stainless Steel Cultivation System is designed to address the current and future needs of the biopharmaceutical industry. Its features, such as the ability to cultivate various cell lines, potential for automation, and focus on sustainability, make it a valuable asset in vaccine production, biopharmaceutical manufacturing, R&D, and contract manufacturing sectors.
For more detailed information ,welcome to join us on Tofflon Stand Hall3.0 A25, Achema 2024 ,Frankfurt ,Germany.
or send email to [email protected]
Redeem our voucher code : A_yAcsgsMH
Please redeem the voucher code at: www.achema.de/en/tickets
